Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
| Image |  |
|---|---|
| Description | article by David A Wolk et al published 1 September 2018 in JAMA Neurology |
| Author/s |
author: Marilyn S. Albert Steen G. Hasselbalch Lennart Minthon Juha O. Rinne Andrea Cherubini |
| Publication date | September 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |